Based on the findings of postmortem brain studies, the cortical parvalbumin-positive GABAergic neurons are impaired in the prefrontal cortex of patients with schizophrenia1,17, and GABAergic compounds are challenged to compensate for the dysfunction of the GABAergic neurons in schizophrenia patients18–20. This evidence concerns the gene PVALB and schizophrenia.